Machine Learning Models Combined with Virtual Screening and Molecular Docking to Predict Human Topoisomerase I Inhibitors.

Journal: Molecules (Basel, Switzerland)
Published Date:

Abstract

In this work, random forest (RF), support vector machine, k-nearest neighbor and C4.5 decision tree, were used to establish classification models for predicting whether an unknown molecule is an inhibitor of human topoisomerase I (Top1) protein. All these models have achieved satisfactory results, with total prediction accuracies from 89.70% to 97.12%. Through comparative analysis, it can be found that the RF model has the best forecasting effect. The parameters were further optimized to generate the best-performing RF model. At the same time, features selection was implemented to choose properties most relevant to the inhibition of Top1 from 189 molecular descriptors through a special RF procedure. Subsequently, a ligand-based virtual screening was performed from the Maybridge database by the optimal RF model and 596 hits were picked out. Then, 67 molecules with relative probability scores over 0.7 were selected based on the screening results. Next, the 67 molecules above were docked to Top1 using AutoDock Vina. Finally, six top-ranked molecules with binding energies less than -10.0 kcal/mol were screened out and a common backbone, which is entirely different from that of existing Top1 inhibitors reported in the literature, was found.

Authors

  • Bingke Li
    a Institute of Functional Molecules, College of Chemistry and Life Science , Chengdu Normal University , Chengdu , China.
  • Xiaokang Kang
    Institute of Functional Molecules, College of Chemistry and Life Science, Chengdu Normal University, Chengdu 611130, China. KXK2799956460@163.com.
  • Dan Zhao
    Key Laboratory of Hunan Province for Water Environment and Agriculture Product Safety, College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, China.
  • Yurong Zou
    Institute of Functional Molecules, College of Chemistry and Life Science, Chengdu Normal University, Chengdu 611130, China. zyrlia1018@163.com.
  • Xudong Huang
    Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, United States.
  • Jiexue Wang
    Institute of Functional Molecules, College of Chemistry and Life Science, Chengdu Normal University, Chengdu 611130, China. xueer0702@163.com.
  • Chenghua Zhang
    School of Basic Medical Sciences, North Sichuan Medical College, Nanchong 637000, China. zchua@nsmc.edu.cn.